Sentences with phrase «many tumor patients»

The Korle Bu Teaching Hospital has announced the closure of three surgical clinics from February 6, 2016, a move that is set to worsen the plight of brain and spinal tumor patients seeking remedy.

HBI member V. Wee Yong, PhD and research associate Susobhan Sarkar, PhD, and their team including researchers from the Department of Clinical Neurosciences and the university's Southern Alberta Cancer Research Institute, looked at human brain tumor samples and discovered that specialized immune cells in brain tumor patients are compromised.

«And in this study, we have formally demonstrated for the first time that these cells are compromised in living brain tumor patients.»

This data warrants further testing of the long - term cardioprotective benefit of an mTORKi in neuroendocrine tumor patients prone to carcinoid syndrome.

Preul and the team came to their results by using the confocal laser endomicroscope on 74 brain tumor patients.

In early clinical trials, Sessler and his colleagues treated 39 metastatic brain tumor patients with texaphyrins 2 hours before radiation therapy for 10 days.

His laboratory at the German Cancer Research Center in Heidelberg and at the Medical Faculty Mannheim of Heidelberg University is studying the mechanisms of metastasis with the goal to develop more gentle supportive adjuvant therapies for tumor patients without detectable metastases following surgery of the primary tumor.

The researchers grafted breast or lung tumors in mice, allowed the tumors to grow to small size and removed these tumors surgically — essentially mimicking the situation in a human tumor patient in which the tumor is surgically removed as soon as possible after diagnosis.

Many tumor patients are consequently treated with chemotherapy after surgery to fight metastasis.

Gregory Foltz of Swedish Medical Center in Seattle saw that BEX1 was turned off in the brains of his tumor patients, and using the Brain Atlas, he confirmed that the gene is usually active in healthy brains, as reported in Cancer Research in 2006.

Their promising results do not mean that the treatment can already be as effective in brain tumor patients.

More information: MACC1 is an independent prognostic biomarker for survival in Klatskin tumor patients, Hepatology; 2015; 62:841 - 850

The percentage of Hodgkin lymphoma and Wilms tumor patients treated with radiation fell from 96 to 77 percent and 77 to 49 percent respectively.

Our team combines patient - centered comprehensive care with state - of - the - art technology and research to provide the best possible outcomes for pediatric brain tumor patients.

Almost all brain and pituitary tumor patients undergo repeated MRI scans after treatment to observe for the possible recurrence of their tumors.

Biodegradable BCNU polymer implants are approved for clinical trials, conducted by Cancer Center investigators, in brain tumor patients.

This group provides an opportunity for brain tumor patients, caregivers, and families to support, share and educate each other.

The researchers said that in the future, smart fat cells will deliver chemotherapeutic drugs, along with contrast agents, to brain tumor patients so that cancer cells can be detected and wiped out in one step.

He is a physical therapist who suddenly became a meningioma brain tumor patient.

In general, brain tumor patients treated with radiation therapy tolerate treatment extremely well.

Three - dimensional CT based radiation therapy is performed on all brain tumor patients at ACIC.

Studies include the investigation of chemotherapeutic agents, novel chemotherapy dosing regimens, and imaging of tumor patients as it relates to radiation therapy.

San Diego, CA USA About Blog A physical therapist who suddenly became a meningioma brain tumor patient.

He is a physical therapist who suddenly became a meningioma brain tumor patient.

Hewlett, NY About Blog The Musella Foundation For Brain Tumor Research & Information, Inc is a nonprofit public charity dedicated to helping brain tumor patients through emotional and financial support, education, advocacy and raising money for brain tumor research.

There are a variety of medications that can help brain tumor patients using targeted destruction of presence of the tumor, such as motor skills, speech, muscle strength and cognitive processes.

He is a physical therapist who suddenly became a meningioma brain tumor patient.

He is a physical therapist who suddenly became a meningioma brain tumor patient.

Not exact matches

Our partner physicians use data and analytics to do exactly what you described, which is to determine the best protocol for patient care — disease and tumor - specific — so they don't over-treat or waste resources.

Led by Nina Bhardwaj, M.D., director of immunotherapy, the Personalized Genomic Vaccine trial uses the genetic sequence of a patient's tumor to create a customized vaccine.

The vaccine in turn will attack targets that arise from genetic mutations in the patient's tumor.

The first step in the process is to surgically remove the patient's tumor and ensure that the patient is cancer free by confirming that there is no sign of cancer on blood tests and imaging studies.

Immune cells modified by CRISPR - Cas9 were inserted into a lung cancer patient at the West China Hospital in Chengdu in the hopes that they'll be able to fight tumors, and 10 people total will receive injections of CRISPR re-engineered cells in order to assess the method's safety.

It will focus its initial clinical sequencing efforts on cancer, teaming up with the Moores Cancer Center at the University of California, San Diego to sequence the genomes of every patient who is treated there, as well as perform a full genome sequence on their tumors.

Merck took a precision approach and targeted its medication towards patients whose tumors express the PD - L1 protein, enrolling these individuals in clinical trials.

But a late - stage clinical trial called CheckMate - 026 for the drug failed to meet its primary goal of halting cancer progression in advanced, untreated patients whose tumors consisted of at least 5 % PD - L1.

These modified cells are then put back into patients in order to attack cancerous tumors.

They are finding cancerous tumors that are in phase 0 and 1 in patients who are experiencing no pain, whereas most people are often diagnosed in phase 4, where pain is prevalent and the disease is more difficult to beat.

The institute, which includes over 40 laboratories and more than 300 researchers, said the research would focus on modifying a patient's own immune system T - cells to target a tumor, studying ways to boost patient response to current immunotherapy drugs.

The indication now covers patients with bone metastases from solid tumors and those with multiple myeloma.

CAR - T cell therapy is a form of immunotherapy, a rapidly developing cancer treatment that uses patients» own immune cells to attack tumors.

When Jedd Wolchok, a cancer doctor and immunologist leading a Yervoy trial at Memorial Sloan Kettering, examined a melanoma patient's scan 12 weeks after he'd received his course of treatment, the results were utterly disappointing — just like those of any other metastatic patient in the final throes of the disease: The tumors had gotten bigger, and there were more of them.

The original pharmaceutical company was in the process of developing Annamycin, a drug that selectively kills highly resistant tumors, especially patients suffering from AML (Acute Myeloid Leukemia).

Patients in the trial had advanced NSCLC, and their tumors tested positive for PD - L1 levels of 50 % or more.

BioNTech hit the headlines in July when its experimental personalized cancer vaccine, tailored to the tumors of individual patients, kept disease in check in an early - stage clinical trial.

MEG TIRRELL, NIGHTLY BUSINESS REPORT CORRESPONDENT: Since they were approved in 2014, drugs that stimulate the immune system have been giving new hope to patients with melanoma, kidney cancer, lymphoma and other cancers, including famously to President Jimmy Carter, who credited the drug called Keytruda with shrinking tumors that had spread to his brain.

Predicine has launched a new liquid biopsy panel called PredicineATLAS, which covers 600 genes and offers a readout of patients tumor mutational burden to help inform and assess immuno - oncology treatment.

CB - 1158 is being tested in a Phase I clinical trial in patients with solid tumors.»

The targeted radiotherapy shrank tumors for 71 % of patients who had already failed standard chemotherapy, but these results came from a small trial that started with 30 patients and then added another 20 after positive data started rolling in.

Around four - fifths of prostate cancer patients have tumors with lots of PSMA for the therapy to bind to.